tiprankstipranks
Burcon Nutrascience (BRCNF)
OTHER OTC:BRCNF

Burcon Nutrascience (BRCNF) Stock Price & Analysis

64 Followers

BRCNF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.01 - $0.51
Previous Close$0.25
Volume50.00
Average Volume (3M)25.81K
Market Cap
$29.41M
Enterprise Value$32.79M
Total Cash (Recent Filing)C$675.38K
Total Debt (Recent Filing)C$5.32M
Price to Earnings (P/E)-5.4
Beta1.03
Jun 19, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding121,790,530
10 Day Avg. Volume26,876
30 Day Avg. Volume25,809
Standard Deviation0.38
R-Squared0.07
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)-10.18
Price to Sales (P/S)82.83
Price to Cash Flow (P/CF)-6.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

50.82%0.41%0.04%48.73%
50.82% Insiders
0.04% Other Institutional Investors
48.73% Public Companies and
Individual Investors

BRCNF FAQ

What was Burcon Nutrascience’s price range in the past 12 months?
Burcon Nutrascience lowest stock price was $0.01 and its highest was $0.51 in the past 12 months.
    What is Burcon Nutrascience’s market cap?
    Currently, no data Available
    When is Burcon Nutrascience’s upcoming earnings report date?
    Burcon Nutrascience’s upcoming earnings report date is Jun 19, 2024 which is in 45 days.
      How were Burcon Nutrascience’s earnings last quarter?
      Burcon Nutrascience released its earnings results on Feb 14, 2024. The company reported -$0.015 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.015.
        Is Burcon Nutrascience overvalued?
        According to Wall Street analysts Burcon Nutrascience’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Burcon Nutrascience pay dividends?
          Burcon Nutrascience does not currently pay dividends.
          What is Burcon Nutrascience’s EPS estimate?
          Burcon Nutrascience’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Burcon Nutrascience have?
          Burcon Nutrascience has 121,731,530 shares outstanding.
            What happened to Burcon Nutrascience’s price movement after its last earnings report?
            Burcon Nutrascience reported an EPS of -$0.015 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5%.
              Which hedge fund is a major shareholder of Burcon Nutrascience?
              Currently, no hedge funds are holding shares in BRCNF
              ---

              Burcon Nutrascience Stock Smart Score

              Company Description

              Burcon Nutrascience

              Burcon NutraScience Corp. engages in the development of valuable plant-based proteins. It also develops a portfolio of composition, application, and process patents originating from a core protein extraction and purification technology. The firm's products include CLARISOY, Peazazz, Canola proteins, and Cannabis. Burcon NutraScience was founded on November 3, 1998 and is headquartered in Vancouver, Canada.
              ---

              BRCNF Earnings Call

              Q3 2024
              0:00 / 0:00
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Ingredion
              Hain Celestial
              Flowers Foods
              Adecoagro SA
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis